Health Karma Inc.
Shareholder Policy
Investor Relations Update April 23, 2025
We are pleased to provide the following updates on recent developments and financial matters.
Restructured Board of Directors:
On April 18, 2025, Health Karma welcomed three accomplished leaders to our Board of Directors: Susan Poniatowski, Garth Walker, and Gene Shvedov. These appointments reflect our commitment to assembling world-class expertise as we enter our next phase of strategic growth.
Our new Directors bring complementary strengths:
• Susan Poniatowski: Proven leadership in governance and financial strategy
• Gene Shvedov: Track record of scaling businesses and accounting/financial excellence
• Garth Walker: Unique blend of technical and investment expertise
For full details on the new Directors’ backgrounds, please refer to the 8-K filed April 23, 2025.
As part of our natural evolution, we accepted the resignation of departing Directors Travis Jackson and John Marino and thanked them for their contributions. Mr. Jackson will now focus entirely on his CEO role, allowing him to dedicate his full energy to executing Health Karma's vision and to evaluating strategic opportunities for the Company.
We're excited about the fresh perspectives and deep experience our renewed Board brings to guide Health Karma's future success.
Strategic Business Developments:
We're pleased to announce our new partnership with Transcend Health (Glendale, CA), a healthcare innovator delivering preventive care through mobile medical units, on-site kiosks, and digital platforms. This collaboration will deploy our virtual behavioral health, telemedicine, and Workers 1st Moment triage solutions to their network, particularly serving unions and first responders.
Transcend Health joins our growing roster of reseller partners brought on in Q1 of this year:
• Benalign: https://www.benalign.com/
• Safe4r: https://www.safe4r.com/
• First Response Mental Health: PeerConnect app for first responders https://firstresponsemh.com/
These partnerships position us for meaningful growth beginning as early as Q3 2025.
Closing Remarks:
We remain steadfast in our focus on driving growth, fostering innovation, and delivering value to our stakeholders. Thank you for your continued support and confidence in our mission as we work to create meaningful impact and achieve long-term success.
For further inquiries, please contact us via:
• Email: IR@healthkarmagroup.com
• Voice Message: (954) 737-3435
• Investor Relations Tab: https://www.healthkarmagroup.com/
Yours in health and progress,
Health Karma Investor Relations